SCHEMBL7228201

SCHEMBL7228201

N#Cc1ccc(CN2CCc3ccc(C(=O)CCCC4CCN(Cc5ccccc5Cl)CC4)cc3CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ACHE P22303 17/20 0.58
FAAH O00519 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7228116 0.93 ACHE (0.56) ACHEFAAH
SCHEMBL7237156 0.90 ACHE (0.58) ACHEFAAH
Hydrochloric Acid SCHEMBL7236861 0.90 ACHE (0.64) ACHEFAAH
SCHEMBL7239342 0.89 ACHE (0.59) ACHEFAAH
Hydrochloric Acid SCHEMBL7227351 0.88 ACHE (0.58) ACHEFAAH
Hydrochloric Acid SCHEMBL7226809 0.88 ACHE (0.58) ACHEFAAH
Hydrochloric Acid SCHEMBL7227835 0.86 ACHE (0.54) ACHEFAAH
SCHEMBL7227784 0.85 ACHE (0.60) ACHEFAAH
SCHEMBL7234946 0.85 ACHE (0.60) ACHEFAAH
SCHEMBL7235363 0.85 ACHE (0.70) ACHEFAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6534496-B1 Prophylactic and/or therapeutic drug for obesity and obesity associated diseasestor diabetes with a reduced risk for central side effects and high universality in usage. Another object of the a lipolytic agent, or a prophylactic and/or TAKEDA CHEMICAL INDUSTRIES, INC. (JP) 2003-03-18 US disclosed
EP-0975624-A1 THERMOGENIC COMPOSITION AND BENZAZEPINE THERMOGENICS Takeda Chemical Industries, Ltd. (JP) 2000-02-02 EP disclosed
WO-1998046590-A1 THERMOGENIC COMPOSITION AND BENZAZEPINE THERMOGENICS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1998-10-22 WO disclosed